Here's What The Latest Ardelyx Inc (ARDX) Data Means For The Company Going Forward
Ardelyx Inc (NASDAQ:ARDX) just put out data from a phase III study in patients with end stage renal disease, and the company is running up on the back of the news.
Ardelyx Inc. (ARDX)
Market is closed
News
- First
- << Previous
- 41 - 49
Is Ardelyx Inc (ARDX) A Good Stock To Buy Right Now?
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash...
RA Capital's Top Q2 Performers; Predicts Big Things Ahead for Pharma Stocks
RA Capital Management LLC is a crossover fund manager that invests in public and private healthcare and life science companies developing drugs, medical devices and diagnostics.
Ardelyx (ARDX): RA Capital Management Boosts Stake to 7.7%
Peter Kolchinsky's RA Capital Management has stepped up its interest in Ardelyx Inc. (NASDAQ:ARDX).
Massive Insider Buying Witnessed at 3 Companies, Including This Fresh Acquisition Target
High-ranking executives have more knowledge and insight concerning the state of their companies, the market conditions within their industries, and possible future developments than any analyst or investor...
Here's Why Investors Are Piling Into These Five Stocks
With the VIX fear index retreating by 6.6% today and volatility calming down a bit, investors are snapping up NGL Energy Partners LP (NYSE:NGL), Boyd Gaming Corporation (NYSE:BYD), Sientra Inc (NASDAQ...
Delta Air Lines Inc. (DAL), Ardelyx Inc. (ARDX) & Exa Corp (EXA) Witnessing Insider Buying Activity
Unquestionably, most companies’ officers and directors have more up-to-date insights about their companies’ ongoing challenges, future prospects and other industry-specific issues.
Is Ardelyx Inc (ARDX) A Good Stock To Buy?
The market has been volatile as the Federal Reserve winds down its easy money policies.
Ardelyx Inc (ARDX): RA Capital Management Discloses 7.3% Passive Stake
RA Capital Management, led by Peter Kolchinsky, has opened a new position in clinical-stage biopharmaceutical company Ardelyx Inc (NASDAQ:ARDX). A new filing with the U.S.
- First
- << Previous
- 41 - 49
Billionaire Hedge Funds
